Back to Stakeholders

The Patient-Centered Outcomes Research Institute (PCORI) is a Washington, DC–based independent non-profit (501(c)(1)) created by the 2010 Affordable Care Act to fund comparative effectiveness research. PCORI awarded $12.6 million to Yale University researchers to directly compare IV racemic ketamine versus intranasal esketamine (Spravato) for treatment-resistant depression, and separately funded the ELEKT-D ketamine vs. ECT effectiveness trial conducted through the Cleveland Clinic Foundation.

Foundations & Philanthropy Snapshot

Grant-Making Organizations

Classification

Public Charity / Non-Profit

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research FundingClinical Trial Funding

Support Types

Grant Funding

Philanthropy Notes

Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Verified against official PCORI funding opportunity pages.

Primary Funding Link

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

3